This week, the Cannabis Health Symposium came to Germany for the first time, bringing healthcare professionals, researchers, policymakers and industry operators to Mainhaus in Frankfurt on Wednesday, 4 November. Coming […]
Ahead of the Cannabis Health Symposium Frankfurt next month, Dr Shabnam Sarshar discusses the growing demand for medical cannabis among women, the gaps in clinical evidence, and why female-specific research is urgently needed.
The Cannabis Health Symposium Frankfurt will bring together experts from across Germany’s medical cannabis sector. Here’s what to expect from every session.
This autumn, a number of events across the UK and Europe will put conversations about women’s health centre stage.
Officials are working on more definitive guidelines around driving and medical cannabis ahead of Cannabis Health Symposium later this year.
The flagship London event relocates to Woolwich Works after record demand, with two further European events to be revealed over the coming weeks
Women’s health will be front and centre at the Cannabis Health Symposia in Frankfurt and London this autumn.
Where legitimate risk management tips over into discrimination against a lawfully treated employee, and how to tell the difference.
Practical guidance for HR teams, managers and leadership.
Professor David Nutt has been announced as a key speaker at the Cannabis Health Symposium in London later this year.
There remains debate within policing over how prescribed medical cannabis patients should be dealt with safely at the roadside.
Early-bird tickets for the Cannabis Health Symposium’s return to London close on Friday, September 4, with the £175 rate rising to standard pricing once the window shuts. The full-day event […]
What employees should tell employers, and what employers can legally ask.
In the eight years since, the NHS has issued just five prescriptions for unlicenced specials cannabis medicines, creating a two-tier system with access only to those who can afford to pay for it.
Understanding the difference between legal treatment and workplace safety concerns.
‘Without a clear policy, employers are more likely to be influenced by their understanding of recreational drug use.’
Findings point to differences in risk perception, communication and confidence discussing cannabis in cancer care.
In a first-of-its-kind clinical trial, researchers found that people who took THC and CBD had significantly less agitation compared to people who received a placebo.
Inhaled cannabis was associated with ‘large, sustained, and statistically robust improvements’ in pain and disability.
Europe’s dedicated medical cannabis education series for clinicians and industry professionals announces two autumn events — 4 November at Mainhaus, Frankfurt, and 26 November at Conway Hall, London
Cannabis-derived molecules could help relieve chronic pain without the psychoactive effects associated with THC.
UK imports of the medical cannabis and the range of products available to patients both doubled in 2025.
Curaleaf Laboratories, one of the UK’s leading manufacturers and distributors of EU-GMP medical cannabis products and Herdade das Barrocas (HDB), a Portuguese cultivator known for its cannabis genetics and cultivation expertise, […]
Despite medical cannabis being legal in the UK for almost eight years, many patients remain hesitant or unsure about whether it is right for them. While awareness of the legality […]
